| Ytd | -9.23% | |
| 1y | -17.81% |
| Open | 6.37 | Prev Close | 6.50 | Low | 6.17 | High | 6.45 | Mkt Cap | 1.15B |
| Vol | 1.95M | Avg Vol | 4.69M | EPS | -0.99 | P/E | N/A | Forward P/E | -8.27 |
| Beta | 2.12 | Short Ratio | 4.18 | Inst. Own | 86.98% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-28 | 50-d Avg | 7.92 | 200-d Avg | 6.71 | 1yr Est | 7.74 |
Teladoc Health said on Monday it appointed Michael Grasher as its chief financial officer, bringing
Appointment brings seasoned financial leadership as Teladoc Health advances its strategy aimed at de
Appointment brings seasoned financial leadership as Teladoc Health advances its strategy aimed at de
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock?
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
TDOC's BetterHelp faces a capacity crunch as insurance demand surges, putting therapist recruitment
NEW YORK, Aug. 20, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
NEW YORK, Aug. 18, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be lim
California State Teachers Retirement System raised its stake in shares of Teladoc Health, Inc. (NYSE
NEW YORK, Aug. 13, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
NEW YORK, Aug. 11, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
Teladoc Health shares fell more than 28% after the Company reported Q2 2026 revenue of $606.9 millio
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc
NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder righ
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Teladoc
Teladoc Health reported Q2 2026 revenue of $606.9 million against consensus estimates of $615 millio
Five months after guiding full-year 2026 consolidated revenue to a range of $2.47 billion to $2.59 b
Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and lower
Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular
Canaccord Genuity analyst Richard Close maintains Teladoc Health (NYSE:TDOC) with a Buy and lower
Evercore ISI Group analyst Elizabeth Anderson maintains Teladoc Health (NYSE:TDOC) with a In-Line
Teladoc Health shares slid in Thursday's premarket after Q2 results and a cautious outlook tempe
Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session.
U.S. stock futures rise, Meta shares drop 9.4%, Teladoc Health and Rentokil Initial fall after mixed
Microsoft (NASDAQ: MSFT) reported strong Q4 results, beating revenue and earnings estimates. Shares
Gainers Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market sessio
Teladoc stock is sinking Wednesday after the company reported Q2 results and updated guidance. Here
Teladoc Health (NYSE:TDOC) is looking for Q3 GAAP EPS of $(0.30)-$(0.20) vs $(0.18) analyst estimate
Teladoc Health (NYSE:TDOC) raises FY2026 GAAP EPS guidance from $(1.05)-$(0.75) to $(1.00)-$(0.75) v
Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.21) per share which beat the analyst con
Teladoc One is a model of care delivered as a single, predictive and adaptive experience to drive be
Top analysts change outlook on top names. Baird, Canaccord Genuity, Needham, Stifel, Truist Securiti
Wall Street analysts change outlook on top names. See all rating changes, including upgrades and dow
Canaccord Genuity analyst Richard Close maintains Teladoc Health (NYSE:TDOC) with a Buy and raise
Teladoc Health Inc. (NYSE: TDOC) shares are trending Wednesday as investors take a fresh look at the
Founded in 2019, The Institute of Patient Safety and Quality of Virtual Care is the first PSO dedica
Cathie Wood‘s ARK Invest joined Kalshi’s $1 billion Series F last week at a $22 billion valuation, s
Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and raise
Teladoc Health Inc. shares are tumbling in Thursday's pre-market after mixed quarterly results a
U.S. stock futures up, Nasdaq 100 gains 100 pts. Meta Platforms Inc shares dip 8.2% after Q1 results
Qualcomm shares rose 10.6% in pre-market trading after reporting better-than-expected Q2 results. Ot
Teladoc stock is trading lower after reporting first-quarter financial results. Here are the highlig
Teladoc Health (NYSE:TDOC) narrows FY2026 GAAP EPS guidance from $(1.10)-$(0.70) to $(1.05)-$(0.75)
Teladoc Health (NYSE:TDOC) is looking for Q2 GAAP EPS of $(0.30)-$(0.20) vs $(0.23) analyst estimate
Teladoc Health (NYSE:TDOC) reported quarterly losses of $(0.36) per share which missed the analyst c